QT Vascular submits IDE requesting permission to begin pivotal trial of its drug-coated Chocolate Balloon in the United States

SINGAPORE, 25 April 2016 – QT Vascular Ltd. (the “Company” or “QT Vascular”, and together
with its subsidiaries, the “Group”), a global company engaged in the design, assembly and
distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular
disease, announced today it has submitted an investigational device exemption (“IDE”) for
permission to begin the pivotal study of Chocolate Touch™, its drug-coated balloon, in the United
States (“US”).

QT Vascular submits IDE requesting permission to begin pivotal trial of its drug-coated Chocolate Balloon in the United States Read More »

DocuSign Forms Strategic Alliances with Deloitte Digital and Cisco to Bring New Value to Customers

SAN FRANCISCO, April 6, 2016 /PRNewswire/ — DOCUSIGN MOMENTUM ’16 – As
part of its drive to help companies of all sizes and industries accelerate their digital
transformation, DocuSign, Inc. announced today that it is joining forces with Deloitte
Digital and Cisco to bring the power of eSignature and Digital Transaction Management
(DTM) to their ecosystems of customers, partners, suppliers and employees.

DocuSign Forms Strategic Alliances with Deloitte Digital and Cisco to Bring New Value to Customers Read More »

DocuSign and IBM Strike Strategic Global Partnership to Drive Digital Trust Globally on IBM Cloud

SAN FRANCISCO, April 6, 2016 /PRNewswire/ — DOCUSIGN MOMENTUM ’16 – With
digital transformation among the top strategic objectives on executive priority lists
everywhere, DocuSign, Inc. today announced a strategic global partnership with IBM
designed to advance digital trust across organizations of every size and industry by
embedding eSignature and Digital Transaction Management (DTM) functionality into IBM’s
software and services.

DocuSign and IBM Strike Strategic Global Partnership to Drive Digital Trust Globally on IBM Cloud Read More »